Stonepine Capital, L.P., 10% Owner at NOVELION THERAPEUTICS INC. (NVLNF), bought 6,242 shares at $0.69 ($4K) on 2019-12-10, disclosed to the SEC on 2019-12-12.
Open-market purchase of $4k NVLNF by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.69 | 5,202 | $4K | 83.1% |
| 2 | $0.69 | 40 | $28 | 0.6% |
| 3 | $0.70 | 1,000 | $700 | 16.2% |
| Total | $0.69 avg | 6,242 | $4K | 100% |
| Filing → |
| NVLNF | BUY | 2019-10-16 | $65K | — | Filing → |
| APEN | SELL | 2018-12-31 | $750K | — | Filing → |
| APEN | SELL | 2018-12-28 | $1.5M | — | Filing → |